Olorofim has proven effective in patients with invasive aspergillosis who are not eligible for standard azole therapy while reducing side effects compared to existing treatments. The post First Novel Antifungal for <i>Aspergillus</i> in 20 Years Succeeds in Phase III appeared first on Inside Precision Medicine .